A matter of privacy
From the Hippocratic oath to HIPAA, we value patient privacy.
J.D. CLOUGH

Supplements and the prostate
What should we tell the many men who take supplements for the prostate?
E.A. KLEIN

Mechanical cardiac support: Is the bridge a destination when you’re stuck on it?
Mechanical support of the circulation raises myriad problems. Answers will come, but slowly.
R.M. MILLS

Privacy protection for your patients
On April 14, 2003, almost every medical provider in this country must implement new federal privacy rules. Here’s how.
D.E. NICKELSON, J.E. STEINER, and N. MEHTA

A man with swelling in his left thumb
What is the cause of this patient’s symptoms? A self-test.
R. GURUNLUOGLU, T. DOGAN, and K. CARNEVALE

Isoflavones and the prevention and treatment of prostate disease
Conclusive proof can only come from clinical trials.
M.L. GAYNOR

Mechanical treatment of heart failure
The devices can keep a patient alive while waiting for a transplant, and they might allow a damaged heart to recover.
H.W. NEMEH and N.G. SMEDIRA

  When to consider prophylactic colectomy in ulcerative colitis?
Prophylactic colectomy eliminates the risk of colorectal cancer, but almost always leads to a lower quality of life.
B.A. LASHNER

  Do patients who stop a hepatitis A or B vaccination series have to restart it?
Limited data indicate that neither series need be restarted.
M.J. ALTER

Help your patients control their weight
Despite disheartening statistics, patients are more likely to lose weight if their physicians encourage them to do so.
B.J. MOORE

Erectile dysfunction: Why drug therapy isn’t always enough
We must not neglect the central role of the mind and emotional relationships in sexual physiology.
S.B. LEVINE

Osteoporosis in men
Osteoporosis is a disease not only of women. In men particularly, we need to seek an underlying cause.
A. LICATA

Microalbuminuria and cardiovascular risk
Protein in the urine is bad, even in small amounts. The risks, possible mechanisms, and recommendations.
R. TAGLE, M. ACEVEDO, and D.G. VIDT

The ALLHAT trial. Diuretics still preferred initial drugs for high blood pressure
Diuretics are unsurpassed in lowering blood pressure, reducing clinical events, tolerability, and low cost.
D.G. VIDT

Classified Advertisements